‘If Pfizer had developed Lipitor today it wouldn’t be a white tablet’
FDA guidance on product design has driven demand by pharma for tailored designs for tablet colour, size and shape, specialist consultancy Colorcon told Outsourcing-Pharma.com.
Archives for March 11, 2014
Small molecule investment in Ireland still significant, says IDA
Ireland remains a significant small molecule drug manufacturing hub the Industrial Development Agency (IDA) says, despite a number of API plant closures.
Pfizer invests in Indonesian solid dose facility
Pfizer’s $3.5m expansion of an Indonesian solid oral dose plant will increase capacity by 76%, the company says.
CDSCO analysis reveals prevalence of substandard drugs in India
Nearly a quarter of drugs made in Jammu & Kashmir and 10% of those produced in Himachal Pradesh are substandard according to new testing data published by CDSCO.
CRO Clinipace moves into Asia with acquisition of Choice Pharma
Clinipace Worldwide announced today that it will acquire Choice Pharma, a pan-Asian CRO.